227 related articles for article (PubMed ID: 27222925)
1. Novel pathologic findings in patients with Pelizaeus-Merzbacher disease.
Laukka JJ; Kamholz J; Bessert D; Skoff RP
Neurosci Lett; 2016 Aug; 627():222-32. PubMed ID: 27222925
[TBL] [Abstract][Full Text] [Related]
2. Neural stem cells restore myelin in a demyelinating model of Pelizaeus-Merzbacher disease.
Gruenenfelder FI; McLaughlin M; Griffiths IR; Garbern J; Thomson G; Kuzman P; Barrie JA; McCulloch ML; Penderis J; Stassart R; Nave KA; Edgar JM
Brain; 2020 May; 143(5):1383-1399. PubMed ID: 32419025
[TBL] [Abstract][Full Text] [Related]
3. Neuronal loss in Pelizaeus-Merzbacher disease differs in various mutations of the proteolipid protein 1.
Sima AA; Pierson CR; Woltjer RL; Hobson GM; Golden JA; Kupsky WJ; Schauer GM; Bird TD; Skoff RP; Garbern JY
Acta Neuropathol; 2009 Oct; 118(4):531-9. PubMed ID: 19562355
[TBL] [Abstract][Full Text] [Related]
4. The spectrum of PLP1 gene mutations in patients with the classical form of the Pelizaeus-Merzbacher disease.
Hoffman-Zacharska D; Mierzewska H; Szczepanik E; Poznański J; Mazurczak T; Jakubiuk-Tomaszuk A; Mądry J; Kierdaszuk A; Bal J
Med Wieku Rozwoj; 2013; 17(4):293-300. PubMed ID: 24519770
[TBL] [Abstract][Full Text] [Related]
5. Gait abnormalities and progressive myelin degeneration in a new murine model of Pelizaeus-Merzbacher disease with tandem genomic duplication.
Clark K; Sakowski L; Sperle K; Banser L; Landel CP; Bessert DA; Skoff RP; Hobson GM
J Neurosci; 2013 Jul; 33(29):11788-99. PubMed ID: 23864668
[TBL] [Abstract][Full Text] [Related]
6. The molecular and cellular defects underlying Pelizaeus-Merzbacher disease.
Woodward KJ
Expert Rev Mol Med; 2008 May; 10():e14. PubMed ID: 18485258
[TBL] [Abstract][Full Text] [Related]
7. Pelizaeus-Merzbacher Disease: Molecular and Cellular Pathologies and Associated Phenotypes.
Inoue K
Adv Exp Med Biol; 2019; 1190():201-216. PubMed ID: 31760646
[TBL] [Abstract][Full Text] [Related]
8. Patients lacking the major CNS myelin protein, proteolipid protein 1, develop length-dependent axonal degeneration in the absence of demyelination and inflammation.
Garbern JY; Yool DA; Moore GJ; Wilds IB; Faulk MW; Klugmann M; Nave KA; Sistermans EA; van der Knaap MS; Bird TD; Shy ME; Kamholz JA; Griffiths IR
Brain; 2002 Mar; 125(Pt 3):551-61. PubMed ID: 11872612
[TBL] [Abstract][Full Text] [Related]
9. PLP1-related inherited dysmyelinating disorders: Pelizaeus-Merzbacher disease and spastic paraplegia type 2.
Inoue K
Neurogenetics; 2005 Feb; 6(1):1-16. PubMed ID: 15627202
[TBL] [Abstract][Full Text] [Related]
10. Pelizaeus-Merzbacher disease: on the cusp of myelin medicine.
Elitt MS; Tesar PJ
Trends Mol Med; 2024 May; 30(5):459-470. PubMed ID: 38582621
[TBL] [Abstract][Full Text] [Related]
11. Neurogenetics of Pelizaeus-Merzbacher disease.
Osório MJ; Goldman SA
Handb Clin Neurol; 2018; 148():701-722. PubMed ID: 29478609
[TBL] [Abstract][Full Text] [Related]
12. PLP1 gene duplication as a cause of the classic form of Pelizaeus-Merzbacher disease - case report.
Mądry J; Hoffman-Zacharska D; Królicki L; Jakuciński M; Friedman A
Neurol Neurochir Pol; 2010; 44(5):511-5. PubMed ID: 21082496
[TBL] [Abstract][Full Text] [Related]
13. Diffusion tensor imaging of patients with proteolipid protein 1 gene mutations.
Laukka JJ; Makki MI; Lafleur T; Stanley J; Kamholz J; Garbern JY
J Neurosci Res; 2014 Dec; 92(12):1723-32. PubMed ID: 25156430
[TBL] [Abstract][Full Text] [Related]
14. Pelizaeus-Merzbacher disease.
Koeppen AH; Robitaille Y
J Neuropathol Exp Neurol; 2002 Sep; 61(9):747-59. PubMed ID: 12230321
[TBL] [Abstract][Full Text] [Related]
15. Pelizaeus-Merzbacher disease as a chromosomal disorder.
Yamamoto T; Shimojima K
Congenit Anom (Kyoto); 2013 Mar; 53(1):3-8. PubMed ID: 23480352
[TBL] [Abstract][Full Text] [Related]
16. Deletion of a splicing enhancer disrupts PLP1/DM20 ratio and myelin stability.
Wang E; Dimova N; Sperle K; Huang Z; Lock L; McCulloch MC; Edgar JM; Hobson GM; Cambi F
Exp Neurol; 2008 Dec; 214(2):322-30. PubMed ID: 18835559
[TBL] [Abstract][Full Text] [Related]
17. A novel PLP1 frameshift mutation causing a milder form of Pelizaeus-Merzbacher disease.
Shiihara T; Watanabe M; Moriyama K; Uematsu M; Sameshima K
Brain Dev; 2015 Apr; 37(4):455-8. PubMed ID: 25043250
[TBL] [Abstract][Full Text] [Related]
18. A new polymorphism in the proteolipid protein (PLP1) gene and its use for carrier detection of PLP1 gene duplication in Pelizaeus-Merzbacher disease.
Hobson G; Stabley D; Funanage V; Marks H
Hum Mutat; 2001 Feb; 17(2):152. PubMed ID: 11180600
[TBL] [Abstract][Full Text] [Related]
19. MR-revealed myelination in the cerebral corticospinal tract as a marker for Pelizaeus-Merzbacher's disease with proteolipid protein gene duplication.
Takanashi J; Sugita K; Tanabe Y; Nagasawa K; Inoue K; Osaka H; Kohno Y
AJNR Am J Neuroradiol; 1999; 20(10):1822-8. PubMed ID: 10588103
[TBL] [Abstract][Full Text] [Related]
20. The magnetic resonance imaging spectrum of Pelizaeus-Merzbacher disease: A multicenter study of 19 patients.
Sumida K; Inoue K; Takanashi J; Sasaki M; Watanabe K; Suzuki M; Kurahashi H; Omata T; Tanaka M; Yokochi K; Iio J; Iyoda K; Kurokawa T; Matsuo M; Sato T; Iwaki A; Osaka H; Kurosawa K; Yamamoto T; Matsumoto N; Maikusa N; Matsuda H; Sato N
Brain Dev; 2016 Jun; 38(6):571-80. PubMed ID: 26774704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
